Switch to:
More From Other Websites
Teva’s Valuation Multiples Compared to Other Generic Drug Players Sep 23 2016
Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest Sep 23 2016
Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest Sep 23 2016
Teva: This Is No Generic Downtrend Sep 23 2016
Teva Reports Positive Phase III Tardive Dyskinesia Data Sep 23 2016
[$$] Teva, Allergan Pump Up the Pipelines Sep 22 2016
Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia... Sep 22 2016
Regeneron, Teva Collaborate to Develop Chronic Pain Drug Sep 21 2016
Regeneron to Collaborate With Teva for Fasinumab Drug (REGN, TEVA) Sep 20 2016
Teva, Eli Lilly Have Migraine Treatments in Trial Phases Sep 20 2016
Teva Presents Top-Line Data from Huntington Disease Study Sep 20 2016
Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington... Sep 19 2016
Intel and Teva Partner on Cloud-based Healthcare Solutions Sep 16 2016
Blog Coverage Teva Expands its Injectables Portfolio and Banks on Merck Cubicin Sep 16 2016
Blog Coverage Allergan Boosts its RandD Expenditure and Pours 639m Dollars in the New Merger Sep 16 2016
Blog Coverage Teva Expands its Injectables Portfolio and Banks on Merck Cubicin Sep 16 2016
Teva/Intel Tie up for Huntington's Disease Technology Platform Sep 16 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK